Welcome to Johns Hopkins Health Alerts!

"Johns Hopkins Health Alerts is an excellent site and I have recommended it to several of my friends. Thanks again, and keep up the good work!"
  • - D. Ambrosio


This free public service from Johns Hopkins Medicine helps keep you up to date on the latest breakthroughs for the most common medical conditions which prevent healthy aging.

Get the latest news sent straight to your inbox for FREE. Check all the boxes below for the topics that interest you.
We value your privacy and will never rent your email address

Johns Hopkins Health Alert

When Prostate Cancer Treatment Leads to Osteoporosis

Comments (1)

Men treated with hormone therapy for advanced prostate cancer are at high risk for developing osteoporosis -- fragile bones due to loss of bone mineral density. Men's bones may actually take a double hit because prostate cancer tends to spread to the bones and weaken them. When that happens, the prostate cancer is typically treated with androgen-deprivation therapy, which further contributes to bone loss because androgens help maintain bone density in men.

Research suggests that men can lose two to six percent of their bone mineral density in the first year of androgen-deprivation therapy for prostate cancer. Bone loss continues in the second year but at a much slower rate. Bone loss can result in painful fractures and falls, loss of mobility and independence and a reduced quality of life.

To detect osteoporosis early, men with advanced prostate cancer should undergo regular bone-density screening with dual-energy X-ray absorptiometry (DEXA) scanning. If your doctor determines that you have osteoporosis, effective medications are available to strengthen and protect your bones.

  • First-line therapy for osteoporosis is usually a bisphosphonate, such as alendronate (Fosamax) or zoledronic acid (Reclast), which slows the breakdown of bone.
  • Some men may benefit from a selective estrogen receptor modulator (SERM), including raloxifene (Evista) or toremifene (Fareston).
  • These drugs stimulate bone building and shut down the activity of osteoclasts, which destroy bone.
  • Finally, a promising new drug for osteoporois called denosumab (Prolia) blocks the formation of a protein that causes bone to break down. A study published in the New England Journal of Medicine found that Prolia reduced the risk of vertebral fractures by 62 percent.

 

Posted in Prostate Disorders on January 3, 2013


Medical Disclaimer: This information is not intended to substitute for the advice of a physician. Click here for additional information: Johns Hopkins Health Alerts Disclaimer


Notify Me

Would you like us to inform you when we post new Prostate Disorders Health Alerts?

Post a Comment

Comments

Health Alerts registered users may post comments and share experiences here at their own discretion. We regret that questions on individual health concerns to the Johns Hopkins editors cannot be answered in this space.

The views expressed here do not constitute medical advice, and do not represent the position of Johns Hopkins Medicine or Remedy Health Media, LLC, which has no responsibility for any comments posted on this site.


What are the views on the recent study at Wake Forest and printed in The Oncologist regarding the cautions of prescribing calcium and vitamin D supplements for men at risk of bone loss from hormonal treatment for prostate cancer.

http://www.wakehealth.edu/News-Releases/2012/Study_Questions_Value_of_Calcium_and_Vitamin_D_Supplements.htm#

See pages 171-179 in The Oncologist http://epub.theoncologist.com/i/84734/86

Posted by: rondys10 | January 5, 2013 4:32 PM

Post a Comment


Already a subscriber?

Login

Forgot your password?

New to Johns Hopkins Health Alerts?

Register to submit your comments.

(example: yourname@domain.com)

Customer Service

Registered Users Log-in:

Forgot Password?

Become a Registered User!
It's fast and FREE!
The Benefits of Being a Registered User

Johns Hopkins' Bestsellers
Prostate Disorders

Johns Hopkins Prostate Disorders White Paper

The Prostate Disorders White Paper

This all-in-one comprehensive guide explains everything you need to know about your prostate -- what it is, what it does, and what problems can develop, such as prostatitis, benign prostatic hyperplasia (BPH or enlarged prostate), and prostate cancer. You'll learn key facts about prostate health, discover prostate treatments you never knew existed, and understand what your options are if you're ever diagnosed with prostate cancer.
PLUS, get your FREE Special Report: Prostate Power through this exclusive web-only offer.

Read more or order now


Johns Hopkins Prostate Disorders Bulletin